Drug Trial Radar · NCT03882970
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Jan 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,444
Actual
Start
Apr 1, 2019
Primary completion
Dec 11, 2020
Study completion Jan 4, 2021
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 20, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.
Conditions
- Type 2 Diabetes Mellitus
Interventions
TirzepatideDrug
Administered SC
Insulin DegludecDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)Time frame: Baseline, Week 52
Locations
122 sites in 13 countries. Site status is shown where the registry gives one.
Arkansas Clinical Research
Little Rock, Arkansas
Valley Research
Fresno, California
National Research Institute
Huntington Park, California
National Research Institute
Los Angeles, California
Catalina Research Institute, LLC
Montclair, California
Valley Clinical Trials, Inc.
Northridge, California
National Research Institute
Panorama City, California
Encompass Clinical Research
Spring Valley, California
University Clinical Investigators, Inc.
Tustin, California
Chase Medical Research, LLC
Waterbury, Connecticut
Indago Research & Health Center, Inc.
Hialeah, Florida
East Coast Clinical Research
Jacksonville, Florida
East Coast Institute For Research
Jacksonville, Florida
Bayside Clinical Research, LLC
New Port Richey, Florida
East Coast Institute For Research
Macon, Georgia
Sky Clinical Research Network
Union City, Georgia
Elite Clinical Trials LLLP
Blackfoot, Idaho
Humphreys Diabetes Center
Boise, Idaho
Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho
Springfield Diabetes & Endocrine Center
Springfield, Illinois
Crescent City Clinical Research
Metairie, Louisiana
Endocrine and Metabolic Consultants
Rockville, Maryland
Troy Internal Medicine, PC
Troy, Michigan
International Diabetes Center
Minneapolis, Minnesota
Clinical Research Professionals
Chesterfield, Missouri
Palm Research Center
Las Vegas, Nevada
Palm Research Center
Las Vegas, Nevada
Aventiv Research
Columbus, Ohio
The Corvallis Clinic P.C.
Corvallis, Oregon
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania
Detweiler Family Medicine
Lansdale, Pennsylvania
Office of Dr. Osvaldo Brusco
Corpus Christi, Texas
Consano Clinical Research
Shavano Park, Texas
AXISMED SRL - Bioclinica Research Network
Buenos Aires, Argentina
Centro Médico Viamonte
Ciudad Autonoma de Buenos Aire, Argentina
Instituto Centenario
Ciudad Autonoma de Buenos Aire, Argentina
CENUDIAB
Ciudad Autonoma de Buenos Aire, Argentina
Investigaciones Medicas IMOBA S.R.L.
Caba, Buenos Aires, Argentina
CEDIC-Centro de Investigaciones Clinicas
Caba, Buenos Aires, Argentina
Mautalen Salud e Investigación - Servicio de Endocrinología
CABA, Buenos Aires, Argentina
Showing 40 of 122 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.